Navigation Links
Unisense FertiliTech A/S Secures 24 Million USD in New Capital Investment
Date:12/13/2012

AARHUS, Denmark, December 13, 2012 /PRNewswire/ --

Danish medtech company Unisense FertiliTech A/S announces a new partnership with Oticon Funds investment company William Demant Invest (WDI). WDI owns 32% of Unisense FertiliTech A/S after the purchase of new and existing shares in the company worth 24 million USD.

     (Photo: http://photos.prnewswire.com/prnh/20120918/562489 )

Unisense FertiliTech A/S develops and manufactures products to improve treatment in the field of assisted reproduction.  The company has expanded rapidly in the past 2 years, operating in more than 30 countries worldwide.  In addition to the current hardware and software product offerings, there is an exciting pipeline of products under development which hold significant commercial potential within the IVF industry.

With this new partnership and investment, the company will be in an excellent position to execute its long term development strategy and to accelerate the global expansion of sales of FertiliTech's existing and new products geared towards improving clinical practice in the field of IVF.

"We welcome WDI as an extremely knowledgeable, financially strong and experienced investor with a proven track record in the medtech field. We also look much forward to the benefits and synergies that can be achieved when applying extensive experience from the hearing aid industry to the area of assisted reproduction", says Unisense FertiliTech A/S CEO, Jens Gundersen.

William Demant Invest's CEO, Niels Jacobsen is very satisfied with the new investment and future goals: "We see excellent possibilities with FertiliTech.  It is a very professionally driven organization with a huge potential. In addition, their products and company profile are a good fit with our existing portfolio".

About Unisense FertiliTech A/S (UF)

Unisense FertiliTech A/S was founded in 2003 to develop technology to improve human embryo assessment in assisted reproduction. Initial research using bovine models led the way to collaborations with embryologists in Europe and North America to evaluate our technology for use with human embryos. Towards this end, an instrument incorporating a fully stable incubation environment with integrated time-lapse image acquisition was developed.

Unisense FertiliTech A/S manufactures and sells state-of-the-art instrumentation notably the EmbryoScope® Time-lapse system, the EmbryoViewer® Workstation (Software) and related products, which are EU approved and FDA cleared for clinical use in IVF laboratories. Unisense FertiliTech A/S conforms to the requirements in DS/EN ISO 13485:2012 for production, installation and servicing of IVF incubators and related accessories

The company is involved in numerous international collaborations, and strives to develop embryo assessment algorithms to improve embryo selection and workflow in the assisted reproduction laboratory. Our goal is to promote knowledge building through extensive documentation and retrospective analysis. We are dedicated to providing technology to improve IVF treatment through quantification of embryo development patterns.

About William Demant Invest

WDI is a wholly owned subsidiary of the Oticon Foundation and has consolidated financial statements with the Oticon Foundation. The objective of the Oticon Foundation's investment activities is to achieve a long-term stable return that will secure the Oticon Foundation's capital its obligations under section 3 of the foundation charter. To achieve this, the financial long-term goals are to maintain or increase the real value of investment assets and to provide a relatively stable return to be used for donations and grants.

The Oticon Foundation's statutes mandate that income be used to support the needs of hearing-impaired individuals as well as organizations. Income is derived through its operational activities in William Demant Invest.

Having a long history, the Oticon Foundation sponsors social and educational programs, publications, conferences, cultural activities and campaigns - both for researchers, hearing-care professionals and the general public.

website  http://www.fertilitech.com



'/>"/>
SOURCE Unisense FertiliTech A/S
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unisense FertiliTech A/S sichert 24 Millionen USD an neuen Kapitalinvestitionen
2. Biomatrica Secures Financing of $5 Million
3. SurgiQuest, Inc. Secures Additional $18.5 Million Funding to Fuel Worldwide Expansion and Commercialization Efforts
4. Zafgen Secures $21 Million in Series D Financing
5. Flexion Therapeutics Secures $20 Million in Series B Financing
6. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
7. ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
8. BioMotiv Secures $21 million in Initial Funding
9. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
10. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
11. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... VENICE, Fla. , Feb. 5, 2016 /PRNewswire/ ... Centers , is the first of its kind ... of undesired tattoos through advanced laser treatment. The ... Florida,s Suncoast by storm with ... video consultations, and advanced multi-wavelength Astanza Trinity technology. ...
(Date:2/5/2016)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the world,s largest ... dental, animal health and medical practitioners, announced today that ... majority ownership interest in Dental Cremer S.A., a distributor ... . --> ... dental distribution business of Cremer S.A. With 2015 sales ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Calls Blacklist has just been updated by ... design and the developer has fixed known bugs within the app. Calls Blacklist allows ... phone while not consuming any of their device’s battery power or memory. It provides ...
(Date:2/5/2016)... CA (PRWEB) , ... February 05, 2016 , ... –This ... on the benefits of having a tankless water heater. To view the report, ... water heaters: tank and tankless. While each has their pros and cons, the type ...
(Date:2/5/2016)... ... 05, 2016 , ... When one is tired of trying to cram belongings into spare space ... to rent a storage unit, but before hastily spending money on a unit, take these ... more space. But what one is often not told when utilizing these services are some ...
(Date:2/4/2016)... ... 2016 , ... According to a recent article published January 21st ... six months for a cleaning and checkup, depending on a patient’s individual needs, appropriate ... at Calabasas Dental Group and California Dental Care, notes that for patients with a ...
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... expanded their services by adding School Psychologist, Cristina M. Olaechea, Ed.S. ... Mrs. Olaechea is highly trained in administering psychoeducational testing in order to assess ...
Breaking Medicine News(10 mins):